Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company
Pharmaceutical company

Scilife Pharma Private Limited

Pakistan

Represent this company?Verified companies can submit portfolio corrections, documents and approved company information.Claim / verify profile →
121products
52generics
5therapeutic areas
121current prices
Portfolio intelligence

Therapeutic mix

Unclassified 109HMG-CoA reductase inhibitors 3Fluoroquinolone antibacterials 3Third-generation cephalosporins 2Proton pump inhibitors 2Angiotensin II receptor blockers 2
Sponsored company campaign area · advertising must be clearly disclosed
Company portfolio

Products

121 results
Reset
BrandGenericStrengthFormPackRegistrationCurrent price
B-FormBudesonide + Formoterol200 mcg + 6 mcgInhalation capsule30's082190PKR 568.43
B-FormBudesonide + Formoterol100 mcg + 6 mcgInhalation capsule30's082189PKR 405.74
B-Form DSBudesonide + Formoterol400 mcg + 12 mcgInhalation capsule30's103090PKR 738.63
Cee-InAscorbic acid500 mgChewable tablet40's105210PKR 48.72
ChlorgelChlorhexidine gluconate7.1% w/w (equiv. 4% chlorhexidine)Gel15gm100190PKR 123.24
ChlorgelChlorhexidine gluconate7.1 %Gel10gm100190PKR 82.73
ClaxyClarithromycin250 mgTablet10's089183PKR 478.74
ClaxyClarithromycin500 mgTablet10's089184PKR 797.89
DaclifeDaclatasvir60 mgTablet28's086634PKR 9,080.04
FoxatinFluoxetine20 mgCapsule10's090860PKR 129.66
HydraSodium chloride13.50 gSachet20's083000PKR 437.96
HydroxychloroquineHydroxychloroquine200 mgTablet30's101281PKR 408.12
InsprynAspirin81 mgTablet30's100436PKR 54.74
LepsiraLevetiracetam750 mgTablet30's100439PKR 3,997.31
LepsiraLevetiracetam500 mgTablet30's100438PKR 2,997.98
LepsiraLevetiracetam250 mgTablet30's100437PKR 1,807.98
Lepsira XRLevetiracetam500 mgExtended-release tablet10's100440PKR 1,006.64
LocholAtorvastatin40 mgTablet30's086603PKR 2,255.67
LocholAtorvastatin20 mgTablet30's086602PKR 1,360.13
LocholAtorvastatin10 mgTablet30's086601PKR 803.04